Investment Offers

NeurMedix, Inc.

Regulation A+

NeurMedix, Inc., is a clinical-stage biotechnology company that engages in development of therapeutic products for the treatment of neurological diseases.

Equity Apple

Regulation D

Interested in becoming an Investment Partner? Find Real Estate Investments working for you. We simplify the investment process to make it turn key to invest in various projects that cover a vast area of real estate investment.

*Accredited investor ONLY

A NEW ERA OF INVESTING

ANI undergoes a strict internal selection process to select the companies featured on AmericasNextInvestment.com. Americas Next Investment focus is to place approved Regulation A+ investments offers which is less than 5% of the startups that apply to be featured on AmericasNextInvestment.com. The companies listed on Americas Next Investment must all successfully pass Americas Next Investment’s internal selection process and must be Regulation D or Regulation A+ approved.

Be the first to hear about our investment
opportunities when they launch

BBC
Bloomberg
CNBC
CNN
CNN Money
Forbes
Fox Business
Fox News
Huffpost
iHeart Media
Instagram
MSNBC
SiriusXM
The Wall Street Journal